On February 6th, Croda International Plc, a British specialty chemicals company, announced that it has agreed to acquire Solus Biotech (Solus), a South Korean innovative biotechnology company, for KRW 350 billion (approximately GBP 232 million excluding debt and cash).
Headquartered in Seoul, Solus is involved in various fields, including battery separators, copper foil, electronic materials, and BIO (providing biologically-based materials for the pharmaceutical, cosmetic, and food industries). Additionally, Solus is a comprehensive solution provider for the health and beauty industry …
